GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

  1. Pereira, F.
  2. Serrano, A.
  3. Manzanedo, I.
  4. Pérez-Viejo, E.
  5. González-Moreno, S.
  6. González-Bayón, L.
  7. Arjona-Sánchez, A.
  8. Torres, J.
  9. Ramos, I.
  10. Barrios, M.E.
  11. Cascales, P.
  12. Morales, R.
  13. Boldó, E.
  14. García-Fadrique, A.
  15. Arteaga, X.
  16. Gutierrez-Calvo, A.
  17. Sánchez-García, S.
  18. Asensio, E.
  19. Ramírez, C.P.
  20. Artiles, M.
  21. Vaqué, J.
  22. Parra, P.A.
  23. Villarejo, P.
  24. Muñoz-Casares, C.
  25. Turienzo, E.
  26. Calero, A.
  27. Torrejimeno, I.J.
  28. Prieto, I.
  29. Galindo, J.
  30. Borrego, V.
  31. Marcello, M.E.
  32. Rihuete, C.
  33. Carrasco, J.
  34. Gomez-Quiles, L.
  35. Show all authors +
Journal:
BMC Cancer

ISSN: 1471-2407

Year of publication: 2022

Volume: 22

Issue: 1

Type: Article

DOI: 10.1186/S12885-022-09572-7 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals